- Report
- March 2024
- 183 Pages
Global
From €3242EUR$3,374USD£2,783GBP
€3602EUR$3,749USD£3,092GBP
- Report
- March 2024
- 186 Pages
Global
From €3242EUR$3,374USD£2,783GBP
€3602EUR$3,749USD£3,092GBP
- Report
- October 2023
- 175 Pages
Global
From €4708EUR$4,900USD£4,042GBP
- Report
- June 2021
- 43 Pages
Global
- Report
- February 2020
- 120 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- July 2020
- 68 Pages
Global
From €2402EUR$2,500USD£2,062GBP
The Wearable Artificial Kidney (WAK) is a medical device designed to provide dialysis to patients with end-stage renal disease. It is a portable, battery-powered device that can be worn on the body, allowing patients to move freely while receiving dialysis. The device is designed to mimic the natural functions of the kidneys, filtering waste and excess fluid from the body. It is connected to the patient via a catheter, and the dialysis fluid is circulated through the device.
The WAK market is a rapidly growing segment of the medical device industry, with a focus on providing improved quality of life for patients with end-stage renal disease. The device is designed to provide a more comfortable and convenient dialysis experience, allowing patients to move freely and engage in activities that would otherwise be difficult or impossible.
Companies in the Wearable Artificial Kidney market include NxStage Medical, Baxter International, Fresenius Medical Care, and Asahi Kasei. Show Less Read more